$THRM Balance Sheet | Understand Stock

$THRM

$33.16 +$1.34 (4.21%) Close

$THRM Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Condensed Balance Sheets

In millions of USD, except per-share amounts

	Q3 FY2026 As of Sep 30, 2026	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021
ASSETS
Current Assets:
Cash and cash equivalents
Accounts receivable, net
Inventory:
Raw materials
Work in process
Finished goods
Inventory, net
Other current assets
Total current assets
Property and equipment, net
Goodwill
Other intangible assets, net
Operating lease right-of-use assets
Deferred income tax assets
Other non-current assets
Total assets
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current Liabilities:
Accounts payable
Current lease liabilities
Current maturities of long-term debt
Other current liabilities
Total current liabilities
Long-term debt, less current maturities
Non-current lease liabilities
Pension benefit obligation
Other non-current liabilities
Total liabilities
Shareholders' Equity:
Common Stock:
No par value; 110,000,000 shares authorized 30,710,902 and 30,526,231 issued and outstanding at September 30, 2026 and December 31, 2025, respectively
Paid-in capital
Accumulated other comprehensive loss
Accumulated earnings
Total shareholders’ equity
Total liabilities and shareholders’ equity

Comments